J&J halts final phase of trials of a drug to treat hypertension, says “futile”Â
HQ Team September 7, 2023: Johnson & Johnson has decided to halt an experimental trial, in its final stages, on a drug to
HQ Team September 7, 2023: Johnson & Johnson has decided to halt an experimental trial, in its final stages, on a drug to
HQ Team September 7, 2023: Extreme heat due to climate change, combined with wildfires and desert dust, is having a pernicious effect on
HQ Team September 6, 2023: About 330,000 migrants and refugees continue to cross the dense tropical jungle between Colombia and Panama risking their
HQ Team September 6, 2023: The global marine industry is pulling out six billion tons of sand and sediments, a non-renewable resource, from
HQ Team September 6, 2023: Biocon Ltd., an Indian biopharmaceutical company, has acquired Eywa Pharma Inc., an oral solid dosage manufacturing facility in
HQ Team September 6, 2023: Britain’s Medicines and Healthcare products Regulatory Agency has cleared a vaccine made by Pfizer Inc., and its German
HQ Team September 5, 2023: South American forests had lost their ability to store carbon and were releasing it into the air due
HQ Team September 5, 2023: Australian researchers have discovered an oral drug to treat excess bad cholesterol in the blood, a condition that
HQ Team September 4, 2023: Dengue has claimed the lives of 569 people in Bangladesh since it started in the last week of
HQ Team September 4, 2023: Novo Nordisk, a Danish drugmaker, announced its weight-loss medicine, Wegovy, will be available in the UK in a